A detailed history of First Trust Capital Management L.P. transactions in Catalent, Inc. stock. As of the latest transaction made, First Trust Capital Management L.P. holds 16,388 shares of CTLT stock, worth $1.04 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
16,388
Previous 19,028 13.87%
Holding current value
$1.04 Million
Previous $1.07 Million 7.2%
% of portfolio
0.11%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $148,262 - $160,934
-2,640 Reduced 13.87%
16,388 $992,000
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $309,585 - $329,461
-5,778 Reduced 23.29%
19,028 $1.07 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $1.06 Million - $1.48 Million
24,806 New
24,806 $1.4 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track First Trust Capital Management L.P. Portfolio

Follow First Trust Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on First Trust Capital Management L.P. with notifications on news.